Search

Search results

4300 results found

Treatment Burden Among Older Adults in the United States, 2022.

Publication: Journal Article

Zhang, Audrey D, Emily A Wolfson, Kenneth J Mukamal, Mara A Schonberg, and Bruce E Landon. 2025. “Treatment Burden Among Older Adults in the United States, 2022.”. Journal of the American Geriatrics Society.

Impact and cost-effectiveness of interventions to eliminate hepatitis C virus among people who inject drugs in Haiphong, Vietnam.

Publication: Journal Article

Trickey, Adam, Josephine G Walker, Pham Minh Khue, Tran Thi Hong, Nguyen Thanh Binh, Catherine Quillet, Roselyne Vallo, et al. 2025. “Impact and Cost-Effectiveness of Interventions to Eliminate Hepatitis C Virus Among People Who Inject Drugs in Haiphong, Vietnam.”. The International Journal on Drug Policy 143: 104898.

Adeel Seyal, MD, and Edgar Martinez, MD, Selected to Receive 2025 HMS Shore Fellowship Awards

News: June 12, 2025

Adeel Seyal, MD, (Mentor: Olga Brook, MD) and Edgar Martinez, MD, (Mentor: David Hackney, MD), have each been awarded a prestigious 2025 Harvard Medical School Shore Fellowship Award. The fellowship is part of The Eleanor and Miles Shore Faculty Development Awards Program at Harvard Medical School...

Utilization and spending on lipid lowering therapies in Medicaid from 2018 to 2022

Publication: Journal Article

Beschloss, Alexander, Rishi K Wadhera, and Andrew S Oseran. 2025. “Utilization and Spending on Lipid Lowering Therapies in Medicaid from 2018 to 2022”. American Heart Journal.

Cardiotoxicity of combined pegylated liposomal doxorubicin and bevacizumab therapy: a propensity-matched cohort study and disproportionality analysis

Publication: Journal Article

Hoeger, Christopher W, Arrush Choudhary, Andrea Nathalie Rosas Diaz, Theresa Pinto, Sarah Smalec, Charles Doladille, Rishi K. Wadhera, et al. 2025. “Cardiotoxicity of Combined Pegylated Liposomal Doxorubicin and Bevacizumab Therapy: A Propensity-Matched Cohort Study and Disproportionality Analysis”. BMC Cardio-Oncology.

Targeted delivery of IL-21 neutralizing nanotherapeutics to lymph nodes and kidney allografts attenuates B cell alloimmunity.

Publication: Journal Article

Zhang, Hengcheng, Gianmarco Sabiu, Sungwook Jung, Manuel A Podestà, Jing Zhao, Maya Gempler, Minako Yamamura, et al. 2025. “Targeted Delivery of IL-21 Neutralizing Nanotherapeutics to Lymph Nodes and Kidney Allografts Attenuates B Cell Alloimmunity.”. Kidney International 108 (1): 48-56.

Introducing Dr. Arpita Kulkarni, Co-Director, Functional Genomics and Bioinformatics Core!

News: July 14, 2025

We’re thrilled to welcome Dr. Arpita Kulkarni to BIDMC as Co-Director of the Functional Genomics and Bioinformatics Core. With deep expertise in single-cell biology, genomic technologies, and translational science, Arpita brings a strong track record of bridging cutting-edge omics platforms with...

Orthopedics GME

Anh-Tuan will present our work on Orai1 blockers at ACS Spring 2025

News: February 25, 2025

Anh Tuan will present our work on Orai1 blockers at ACS Spring 2025 (23th - 27th, March, 2025, San Diego). The abstract is available here: https://acs.digitellinc.com/live/34/session/550963 Part of the story has been published last year: https://www.sciencedirect.com/science/article/abs/pii...

Simultaneous Inhibition of PARP/AKT to Intercept Nascent BRCA1/2mut Breast Tumors

Publication: Journal Article

Wang, Lin, Brian R Sardella, Emily K Aronson, Zhaoji Liu, Xiaohui Li, Gerburg M Wulf, and Yujing J Heng. Submitted. “Simultaneous Inhibition of PARP/AKT to Intercept Nascent BRCA1/2mut Breast Tumors”. Submitted, Submitted.